GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS
![]() |
- Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe for New Zealand patients
- YONDELIS® (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine[1]
SINGAPORE and AUCKLAND, New Zealand, Feb. 17, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised...
Read more: GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS